Millennium Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
VPM
VCM
MCMU
Millennium Management's RXRX Position: Q1 2026 in Review
Millennium Management increased its Recursion Pharmaceuticals (RXRX) stake by 75% in Q1 2026, buying an estimated $4.31M and bringing the position to 2,612,277 shares worth $8.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2400.
Millennium Management first reported a position in RXRX in Q4 2021 and has held it in 14 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.
- Millennium Management held 2,612,277 shares of Recursion Pharmaceuticals worth $8.02M as of Q1 2026.
- Millennium Management bought 1,116,438 Recursion Pharmaceuticals shares in Q1 2026, an estimated $4.31M.
- Recursion Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2400 holding.
- Millennium Management first reported a position in Recursion Pharmaceuticals in Q4 2021 and has held it in 14 quarters since.
- 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.